Catalyst Pharmaceuticals stock price
NASDAQ:CPRX · NasdaqCatalyst Pharmaceuticals's chart data is dated 2026-07-16. Recorded technical signals: Near 52-week high, MA aligned. There are 10 published signal records.
Catalyst Pharmaceuticals trades 24/7 on Nasdaq; price and technical signals update daily. Signals today: Near 52-week high, MA aligned. Last annual report PER is 23.6×. The display ticker is CPRX.
About this company
Catalyst Pharmaceuticals last closed at $31.49 (+0.00%) on 2026-07-16. Signals today: Near 52-week high, MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
No overall sector grade is available.
No valuation grade is available.
Related stocks
- AmgenCompetitor
희귀질환·신경근육계 치료제 시장에서 경쟁 관계
- UCBCompetitor
Myasthenia gravis 등 면역·신경질환 치료 영역에서 경쟁
- ArgenxCompetitor
중증 자가면역/희귀질환 치료제에서 직접 경쟁
ETFs holding this stock
Lattice Hartford Multifactor Small Cap ETF
Details →About Catalyst Pharmaceuticals
- What technical signals does Catalyst Pharmaceuticals (CPRX) have?
- Catalyst Pharmaceuticals current technical signals: MA alignment (score 0.61).
- Is Catalyst Pharmaceuticals a cup-and-handle pattern?
- No. Catalyst Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Catalyst Pharmaceuticals?
- Market cap: $3.87B. Last annual report PER: 23.6×. Last annual report PBR: 5.32×.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Catalyst Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.